Pipeline embolization of proximal middle cerebral artery aneurysms: A multicenter cohort study.
Middle cerebral artery
aneurysm
endovascular
pipeline embolization device
Journal
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
ISSN: 2385-2011
Titre abrégé: Interv Neuroradiol
Pays: United States
ID NLM: 9602695
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
pubmed:
7
5
2021
medline:
11
3
2022
entrez:
6
5
2021
Statut:
ppublish
Résumé
Flow diversion of aneurysms located in the M1 segment and middle cerebral artery bifurcation with Pipeline embolization device is sometimes performed, but further study is needed to support its regular use in aneurysm treatment. Here, we report measures of safety and efficacy for Pipeline embolization in the proximal middle cerebral artery in a multi-center cohort. Clinical and angiographic data of eligible patients were retrospectively obtained from participating centers and assessed for key clinical and angiographic outcomes. Additional details were extracted for patients with complications. In our multi-center cohort, complete aneurysm occlusion was achieved in 71% (17/24) of treated aneurysms. There were no deaths or disabling strokes, but non-disabling ischemic strokes occurred in 8% (2/24) of patients. For aneurysms in the M1 segment, complete aneurysm occlusion was observed in 75% (12/16) of aneurysms, aneurysm volume reduction was observed in 100% (16/16) of aneurysms, and non-disabling ischemic strokes occurred in 13% (2/16) of patients. For aneurysms at the middle cerebral artery bifurcation, complete aneurysm occlusion was observed in 63% (5/8) of aneurysms, aneurysm volume reduction occurred in 88% (7/8) of aneurysms, and ischemic or hemorrhagic complications occurred in 0% (0/8) of patients. Pipeline embolization of cerebral aneurysms in the M1 segment and middle cerebral artery bifurcation demonstrated a 71% rate of complete aneurysm occlusion. There were no deaths or disabling strokes, but there was an 8% rate of non-disabling ischemic strokes.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
Flow diversion of aneurysms located in the M1 segment and middle cerebral artery bifurcation with Pipeline embolization device is sometimes performed, but further study is needed to support its regular use in aneurysm treatment. Here, we report measures of safety and efficacy for Pipeline embolization in the proximal middle cerebral artery in a multi-center cohort.
MATERIALS AND METHODS
METHODS
Clinical and angiographic data of eligible patients were retrospectively obtained from participating centers and assessed for key clinical and angiographic outcomes. Additional details were extracted for patients with complications.
RESULTS
RESULTS
In our multi-center cohort, complete aneurysm occlusion was achieved in 71% (17/24) of treated aneurysms. There were no deaths or disabling strokes, but non-disabling ischemic strokes occurred in 8% (2/24) of patients. For aneurysms in the M1 segment, complete aneurysm occlusion was observed in 75% (12/16) of aneurysms, aneurysm volume reduction was observed in 100% (16/16) of aneurysms, and non-disabling ischemic strokes occurred in 13% (2/16) of patients. For aneurysms at the middle cerebral artery bifurcation, complete aneurysm occlusion was observed in 63% (5/8) of aneurysms, aneurysm volume reduction occurred in 88% (7/8) of aneurysms, and ischemic or hemorrhagic complications occurred in 0% (0/8) of patients.
CONCLUSION
CONCLUSIONS
Pipeline embolization of cerebral aneurysms in the M1 segment and middle cerebral artery bifurcation demonstrated a 71% rate of complete aneurysm occlusion. There were no deaths or disabling strokes, but there was an 8% rate of non-disabling ischemic strokes.
Identifiants
pubmed: 33951971
doi: 10.1177/15910199211015578
pmc: PMC8905083
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
50-57Références
Neuropharmacology. 2018 May 15;134(Pt B):226-239
pubmed: 29273521
AJNR Am J Neuroradiol. 2016 Feb;37(2):279-84
pubmed: 26405085
Interv Neuroradiol. 2010 Jun;16(2):133-7
pubmed: 20642887
J Neurosurg. 2019 Jan 11;132(2):473-480
pubmed: 30641842
Scott Med J. 1957 Jun;2(6):254-68
pubmed: 13432842
J Neurosurg. 2017 Apr;126(4):1064-1069
pubmed: 27285547
J Neurointerv Surg. 2020 Jan;12(1):62-66
pubmed: 31308197
Clin Neuroradiol. 2018 Jun;28(2):209-216
pubmed: 27942770
J Neurointerv Surg. 2016 Mar;8(3):287-94
pubmed: 25603808
J Neurosurg. 2018 Dec 21;131(6):1751-1762
pubmed: 30579280
Br J Clin Pharmacol. 2011 Oct;72(4):683-96
pubmed: 21366666
Exp Ther Med. 2019 Sep;18(3):2072-2078
pubmed: 31410163
AJNR Am J Neuroradiol. 2015 Sep;36(9):1728-34
pubmed: 25999412
World Neurosurg. 2018 Oct;118:e825-e833
pubmed: 30026147
AJNR Am J Neuroradiol. 2010 Apr;31(4):E43-4
pubmed: 20150311
Surg Neurol. 1994 Mar;41(3):217-9; discussion 219-20
pubmed: 8146736
World Neurosurg. 2020 May;137:451-464.e1
pubmed: 31972346
J Neurosurg. 2015 Mar;122(3):627-36
pubmed: 25559933
J Neurosurg. 2018 May 4;130(3):923-935
pubmed: 29726768
J Neurointerv Surg. 2017 Feb;9(2):147-151
pubmed: 27382125
World Neurosurg. 2017 Feb;98:809-817.e1
pubmed: 27856383
Neurosurgery. 2018 May 1;82(5):695-700
pubmed: 28541503
Neurosurg Rev. 2021 Jun;44(3):1471-1478
pubmed: 32562019
World Neurosurg. 2017 Jul;103:789-798
pubmed: 28438653
Interv Neuroradiol. 2020 Feb;26(1):68-73
pubmed: 31451027
Clin Neurol Neurosurg. 2017 Sep;160:83-87
pubmed: 28692909
AJNR Am J Neuroradiol. 2014 Mar;35(3):529-35
pubmed: 24072620
Radiology. 2013 Jun;267(3):858-68
pubmed: 23418004
AJNR Am J Neuroradiol. 2012 Sep;33(8):1436-46
pubmed: 22821921
Stroke. 2013 Feb;44(2):442-7
pubmed: 23321438
AJNR Am J Neuroradiol. 2017 Feb;38(2):310-316
pubmed: 27979794
J Neurointerv Surg. 2019 Dec;11(12):1227-1234
pubmed: 31088939
AJNR Am J Neuroradiol. 2017 Nov;38(11):2131-2137
pubmed: 28882859
Front Neurol. 2017 Feb 02;8:20
pubmed: 28210239
Lancet. 2005 Sep 3-9;366(9488):809-17
pubmed: 16139655
AJNR Am J Neuroradiol. 2017 Dec;38(12):2289-2294
pubmed: 28982785
Neurosurgery. 2006 Nov;59(5 Suppl 3):S77-92; discussion S3-13
pubmed: 17053621
J Neurosurg. 2005 Nov;103(5):891-902
pubmed: 16304994
J Clin Neurosci. 2013 Apr;20(4):520-2
pubmed: 23375399
Neurosurgery. 2011 Feb;68(2):397-402; discussion 402
pubmed: 21135730
N Engl J Med. 1998 Dec 10;339(24):1725-33
pubmed: 9867550
J Neurointerv Surg. 2016 May;8(5):481-7
pubmed: 25878068
Interv Neurol. 2016 Jun;5(1-2):89-99
pubmed: 27610126
J Cerebrovasc Endovasc Neurosurg. 2014 Mar;16(1):32-8
pubmed: 24765611
World Neurosurg. 2018 Feb;110:20-25
pubmed: 29107726